Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2016

Jul 12, 2016

30718_dirs_2016-07-12_cc54c952-eab0-4fad-823f-6a09c4f98785.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-07-09

Reporting Person: Gould Kevin S (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-07-09 Common Stock F 309.00 $115.17 Disposed 2191.00 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options (Right to buy) $97.23 2022-07-09 Common Stock (50000.00) 50000.00 Direct
Stock Options (Right to buy) $97.23 2022-07-09 Common Stock (15000.00) 15000.00 Direct
Stock Options (Right to buy) $88.23 2023-01-04 Common Stock (10000.00) 10000.00 Direct

Footnotes

F1: 1. The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock unit gran by directing the Company to withhold shares otherwise issuable pursuant to the previously reported grant.

F2: 2. Includes 833 shares of restricted stock units that vest on 7/9/17 and 834 shares of restricted stock units that vest on 7/9/18.

F3: 4. 50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/2018.

F4: 3. Vests as to 3,750 shares on each of 07/09/16, 07/09/17, 07/09/18 and 07/09/19.

F5: 5. Vests as to 2,500 shares on each of 01/04/2017, 01/04/2018, 01/04/2019 and 01/04/2020.